Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
4151
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.27M | ﹤0.01% |
+35,454
| New | +$1.02M |
|
|
MDSO
4152
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.27M | ﹤0.01% |
20,000
+10,000
| +100% | +$712K |
|
4153
Marcus Corp
MCS
$925M
| $1.26M | ﹤0.01% |
46,280
+1,288
| +3% | +$35.5K |
|
4154
Rithm Capital
RITM
$5.79B
| $1.26M | ﹤0.01% |
70,732
-27,882
| -28% | -$491K |
|
|
AMRN
4155
Amarin Corp
AMRN
$297M
| $1.26M | ﹤0.01% |
15,746
-334
| -2% | -$23K |
|
|
BECN
4156
PUT
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.26M | ﹤0.01% |
19,800
+9,000
| +83% | +$517K |
|
4157
BCE
BCE
$21.9B
| $1.26M | ﹤0.01% |
+26,270
| New | +$1.25M |
|
4158
Teradyne
TER
$65.5B
| $1.26M | ﹤0.01% |
30,112
-508,688
| -94% | -$21M |
|
|
FTR
4159
PUT
DELISTED
Frontier Communications Corp.
FTR
| $1.26M | ﹤0.01% |
186,600
+53,400
| +40% | +$498K |
|
|
MB
4160
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $1.26M | ﹤0.01% |
41,351
-140,119
| -77% | -$4.31M |
|
|
NUVA
4161
PUT
DELISTED
NuVasive, Inc.
NUVA
| $1.26M | ﹤0.01% |
21,500
-3,800
| -15% | -$216K |
|
|
WP
4162
PUT
DELISTED
Worldpay, Inc.
WP
| $1.26M | ﹤0.01% |
17,100
+4,500
| +36% | +$322K |
|
|
TSS
4163
PUT
DELISTED
Total System Services, Inc.
TSS
| $1.26M | ﹤0.01% |
15,900
+6,400
| +67% | +$465K |
|
4164
PUT
WEC Energy
WEC
$36B
| $1.26M | ﹤0.01% |
18,900
+7,200
| +62% | +$483K |
|
|
TUP
4165
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $1.25M | ﹤0.01% |
20,000
-8,600
| -30% | -$527K |
|
4166
PUT
Helen of Troy
HELE
$704M
| $1.25M | ﹤0.01% |
13,000
-5,700
| -30% | -$525K |
|
4167
PUT
Brink's
BCO
$4.71B
| $1.25M | ﹤0.01% |
15,900
+3,700
| +30% | +$300K |
|
4168
Avis
CAR
$4.87B
| $1.25M | ﹤0.01% |
28,504
+7,358
| +35% | +$293K |
|
4169
Impinj
PI
$5.28B
| $1.25M | ﹤0.01% |
55,538
+39,048
| +237% | +$1.12M |
|
4170
Schwab US Dividend Equity ETF
SCHD
$108B
| $1.25M | ﹤0.01% |
+73,335
| New | +$1.2M |
|
|
ENV
4171
CALL
DELISTED
ENVESTNET, INC.
ENV
| $1.25M | ﹤0.01% |
25,100
+9,900
| +65% | +$512K |
|
4172
PUT
ON Semiconductor
ON
$32.2B
| $1.25M | ﹤0.01% |
59,700
-7,300
| -11% | -$149K |
|
4173
Central Garden & Pet Co Class A
CENTA
$2.37B
| $1.25M | ﹤0.01% |
41,373
-1,650
| -4% | -$48.9K |
|
4174
Stock Yards Bancorp
SYBT
$2.64B
| $1.25M | ﹤0.01% |
33,134
+4,152
| +14% | +$159K |
|
|
UMH
4175
UMH Properties
UMH
$1.4B
| $1.25M | ﹤0.01% |
83,831
-27,844
| -25% | -$424K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.